Jesus Corral Jaime, MD, reviews real-world survival and response data for cemiplimab monotherapy from the CEMI-LUNG study.
Jesus Corral Jaime, MD
Advertisement
Articles by Jesus Corral Jaime, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Ivonescimab Combo Improves Survival in Advanced Biliary Tract Cancer
2
Osimertinib/Savolitinib Improves Survival in MET-Altered EGFR-Mutant NSCLC
3
FDA Approves Talazoparib/Enzalutamide for HRR Gene-Altered Metastatic Prostate Cancer
4
How Can Functional Modeling, AI Accelerate Translational Breast Cancer Research?
5